Document Detail


Cutaneous hypersensitivity following peripheral tissue damage in newborn infants and its reversal with topical anaesthesia.
MedLine Citation:
PMID:  2812853     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
The flexion reflex threshold has been used as a measure of sensation in a group of premature infants born at 27-32 weeks postmenstrual age. The threshold in an area of local tissue damage created by routine heel lances was half the threshold on the intact heel on the other side. This indicated a hypersensitivity to tissue damage analogous to tenderness or hyperalgesia reported in adults. In a double-blind study, treatment of the damaged area with the topical anaesthetic cream, EMLA, was found to reverse this hypersensitivity or in other words increase the flexion reflex threshold. Treatment with placebo had no effect. The results show that the newborn infant central nervous system is capable of mounting a chronic pain response to local injury which can be reduced by local anaesthetic.
Authors:
M Fitzgerald; C Millard; N McIntosh
Related Documents :
3818163 - Injury mortality and socioeconomic development: an exploratory analysis.
18230283 - Road crash in china from 2003 to 2005.
12452503 - Risk factors for hospital-acquired infections in the neonatal intensive care unit.
Publication Detail:
Type:  Clinical Trial; Controlled Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Pain     Volume:  39     ISSN:  0304-3959     ISO Abbreviation:  Pain     Publication Date:  1989 Oct 
Date Detail:
Created Date:  1989-12-08     Completed Date:  1989-12-08     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  7508686     Medline TA:  Pain     Country:  NETHERLANDS    
Other Details:
Languages:  eng     Pagination:  31-6     Citation Subset:  IM    
Affiliation:
Department of Anatomy and Developmental Biology, University College London, U.K.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Anesthetics, Local / therapeutic use*
Ankle Injuries*
Blood Specimen Collection / adverse effects,  methods
Double-Blind Method
Drug Combinations / therapeutic use
Female
Humans
Hypersensitivity / drug therapy,  etiology*,  physiopathology
Infant, Newborn
Lidocaine / therapeutic use*
Longitudinal Studies
Male
Prilocaine / therapeutic use*
Reflex / physiology
Sensory Thresholds / drug effects
Skin Diseases / drug therapy,  etiology*,  physiopathology
Wounds, Penetrating / complications
Chemical
Reg. No./Substance:
0/Anesthetics, Local; 0/Drug Combinations; 0/EMLA; 137-58-6/Lidocaine; 721-50-6/Prilocaine

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Modifiers of patient-controlled analgesia efficacy. II. Chronic pain.
Next Document:  Pain, sedation and reaction time during long-term treatment of cancer patients with oral and epidura...